Oscar Health Inc. Reaffirms 2025 Financial Guidance at Wells Fargo Healthcare Conference
Oscar Health Inc. has announced that it will participate in the 2025 Wells Fargo Healthcare Conference on September 3, 2025, where the company plans to reaffirm its updated full-year 2025 financial guidance. This update follows the preliminary financial results press release for the second quarter of 2025, released on July 22, 2025. While specific details of the guidance were not provided in this disclosure, the reaffirmation suggests that Oscar Health remains confident in its financial projections for the year. This information is disclosed under Regulation FD and is not considered filed for the purposes of the Securities Exchange Act of 1934.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oscar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-194448), on September 03, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。